Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-15T01:27:41.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website has updated the contact details and location information for a study, now indicating it is completed and providing a new revision version, while removing previous details about the study's active status.
    Difference
    2%
    Check dated 2024-12-07T23:22:08.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    New recruiting contacts have been added, including multiple Study Coordinators with various phone numbers, while previous entries related to 'Active, not recruiting' and specific Merck Oncology Clinical Trials Information have been removed.
    Difference
    3%
    Check dated 2024-11-30T17:17:43.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has added new features while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    2%
    Check dated 2024-11-23T06:34:38.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Several key health-related links, including those for lung cancer information and clinical trials, have been removed from the website.
    Difference
    0.3%
    Check dated 2024-11-16T02:08:22.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with numerous new resources added related to lung cancer, including links to MedlinePlus and clinical trial information.
    Difference
    3%
    Check dated 2024-11-08T19:21:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.